Short answer
Cigna (CI) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $73.7B (up 5.6% year over year) with net income of $1.4B.
Q3 2026 key financials · XBRL
- Revenue
- $73.7B
- +5.6% YoY · +2.8% QoQ
- Net income
- $1.4B
- −22.8% YoY · −13.1% QoQ
- Operating margin
- 3.3%
- EPS (diluted)
- $5.47
- −21.5% YoY · −13.0% QoQ
Source: XBRL data from the Cigna (CI) Q3 2026 10-Q on SEC EDGAR. USD.
Cigna Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $73.7B, up 6% YoY from $69.7B, driven by pharmacy revenues and higher premiums
- Shareholders’ net income $1.4B, down 23% from $1.9B; adjusted income $2.1B vs $2.1B
- Cigna Healthcare strongest segment: adjusted income $1.2B, up 15%; margin 10.2% vs 9.7%
- Evernorth weakest segment: adjusted income $1.8B, down 4%; margin 2.9% vs 3.2%
- Operating cash flow $3.3B vs $3.5B; repurchases $0.5B vs $2.6B, with inflationary and regulatory headwinds cited
Risk Factors
- No material risk-factor changes reported from the December 31, 2025 Form 10-K
- Regulatory and legal exposure: Risks remain as described in the 2025 annual filing
- Operational and market exposure: Results remain subject to previously disclosed factors
- Financial exposure: Liquidity and financial-condition risks remain unchanged from the 2025 Form 10-K
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Cigna quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.